Figure and Table | Impact of the COVID-19 Pandemic on Health Check-ups: A Nationwide Questionnaire Survey in 639 Healthcare Facilities in Japan Society of Ningen Dock

Table 1. Changes in the Annual Number of Health Check-Ups in 2020 and 2021 Compared with 2019.

Type of Check-ups	Mandatory Check-ups^a	Total numbers^b			Change % for each facility^c
Type of Check-ups	Mandatory Check-ups^a	2019 total	2020 total (change%)	2021 total (change%)	2020 median (IQR)	P value^d	2021 median (IQR)	P value^d	Number of facilities
All check-ups	-	22,061,140	19,861,230 (−10.0)	21,748,125 (−1.4)	−8.3 (−14.6, −3.1)	<0.001	−0.5 (−6.0, +4.9)	0.28	591
Check-ups based on Industrial Safety and Health Act	Yes	2,677,734	2,625,750 (−1.9)	2,798,448 (+4.5)	−3.9 (−11.9, +2.7)	<0.001	+1.9 (−6.7, +11.4)	<0.001	531
Check-ups for prevention of lifestyle-related diseases	Yes	2,682,704	2,522,169 (−6.0)	2,807,206 (+4.6)	−4.4 (−12.1, +1.2)	<0.001	+4.5 (−2.7, +11.9)	<0.001	537
Comprehensive check-ups (Ningen Dock)^e	Yes/No	2,884,244	2,622,728 (−9.1)	2,897,562 (+0.5)	−8.3 (−15.0, −2.7)	<0.001	−0.2 (−7.0, +6.8)	>0.99	563
Specific health check-ups alone^f	No	590,041	495,615 (−16.0)	548,076 (−7.1)	−14.5 (−26.7, −3.4)	<0.001	−3.8 (−18.1, +9.3)	<0.001	513
Cancer screenings by local governments	No	1,254,749	1,028,044 (−18.1)	1,181,612 (−5.8)	−13.2 (−24.6, 0.0)	<0.001	−3.0 (−16.4, +13.8)	0.007	414
Other in-facility check-ups^g	No	1,094,981	1,021,032 (−6.8)	1,097,665 (+0.2)	−10.1 (−21.9, +0.9)	<0.001	−3.6 (−17.5, +10.5)	0.008	526
Check-ups using mobile medical vehicles	Yes/No	10,876,687	9,545,892 (−12.2)	10,417,556 (−4.2)	−10.9 (−18.0, −3.9)	<0.001	−3.8 (−13.2, +1.8)	<0.001	192

Table 2. Changes in the Number of Screenings for Cancer, Diabetes, etc. in 2020 Compared with 2019.

	Total numbers in 2019	Total numbers in 2020 (change %)	Change % for each facility, median (IQR)	P value^a	Number of facilities
Gastric cancer (contrast radiography)	1,183,400	1,095,134 (−7.5)	−7.0 (−15.0, +1.2)	<0.001	366
Gastric cancer (endoscopy)	999,181	856,835 (−14.2)	−9.9 (−19.6, −1.7)	<0.001	360
Colorectal cancer	2,322,061	2,128,041 (−8.4)	−7.8 (−14.4, −3.5)	<0.001	377
Lung cancer	2,519,730	2,293,894 (−9.0)	−8.1 (−14.0, −3.4)	<0.001	377
Breast cancer (mammography)	519,792	472,094 (−9.2)	−8.8 (−15.5, −1.9)	<0.001	370
Breast cancer (ultrasound)	375,503	344,161 (−8.3)	−7.6 (−15.0, +1.8)	<0.001	312
Cervical cancer	660,386	590,999 (−10.5)	−9.5 (−16.8, −2.9)	<0.001	368
Hypertension	2,471,955	2,266,422 (−8.3)	−8.2 (−14.3, −4.1)	<0.001	361
Diabetes	2,442,136	2,239,418 (−8.3)	−8.1 (−14.1, −4.1)	<0.001	360
Dyslipidemia	2,426,457	2,224,723 (−8.3)	−8.1 (−14.2, −4.1)	<0.001	358

Table 3. Difference in the Proportion of Examinees Requiring Follow-Up Visits between 2020 and 2019.

	Rate % in 2019, median (IQR)	Rate % in 2020, median (IQR)	Difference % (2020-2019), median (IQR)	P value^a	Number of facilities
Gastric cancer (contrast radiography)	3.67 (1.72, 7.31)	3.38 (1.52, 6.30)	−0.33 (−1.33, +0.45)	<0.001^b	362
Gastric cancer (endoscopy)	3.41 (1.42, 6.26)	3.28 (1.41, 5.97)	−0.19 (−0.85, +0.41)	<0.001^b	343
Colorectal cancer	5.46 (4.59, 6.46)	5.60 (4.71, 6.50)	+0.06 (−0.41, +0.59)	0.04^c	371
Lung cancer	1.55 (0.80, 2.60)	1.43 (0.76, 2.49)	−0.06 (−0.43, +0.19)	<0.001^b	372
Breast cancer (mammography)	4.62 (2.90, 7.03)	4.60 (2.88, 6.92)	−0.08 (−1.38, +0.94)	0.09	363
Breast cancer (ultrasound)	3.00 (1.66, 5.41)	2.66 (1.46, 4.81)	−0.18 (−1.13, +0.54)	0.005^b	304
Cervical cancer	1.79 (1.03, 3.27)	1.86 (1.08, 3.43)	+0.03 (−0.50, +0.57)	0.43	362
Hypertension	1.42 (0.49, 2.39)	1.62 (0.57, 2.79)	+0.08 (−0.07, +0.41)	<0.001^c	350
Diabetes	1.50 (0.71, 2.91)	1.49 (0.70, 3.06)	+0.01 (−0.16, +0.25)	0.047^c	354
Dyslipidemia	4.26 (1.92, 6.11)	4.45 (2.12, 6.83)	+0.08 (−0.25, +0.70)	<0.001^c	350

Table 4. Difference in Adherence to Follow-Up Visits between 2020 and 2019.

	Rate % in 2019, median (IQR)	Rate % in 2020, median (IQR)	Difference % (2020-2019), median (IQR)	P value^a	Number of facilities
Gastric cancer (contrast radiography)	57.0 (39.3, 69.8)	57.1 (41.2, 69.0)	−0.6 (−6.5, +6.7)	0.80	305
Gastric cancer (endoscopy)	85.5 (59.6, 98.3)	85.0 (64.6, 98.8)	0.0 (−3.4, +4.6)	0.51	296
Colorectal cancer	54.4 (40.7, 67.1)	54.1 (41.4, 65.2)	−0.1 (−4.6, +4.4)	0.63	325
Lung cancer	70.0 (54.1, 82.2)	69.4 (53.8, 81.8)	+0.4 (−7.1, +8.6)	0.15	329
Breast cancer (mammography)	80.9 (62.6, 90.6)	80.3 (62.3, 89.6)	−0.4 (−6.0, +6.8)	0.81	315
Breast cancer (ultrasound)	76.3 (53.8, 90.9)	78.6 (58.3, 91.7)	0.0 (−6.3, +8.3)	0.26	249
Cervical cancer	70.0 (52.4, 85.7)	71.4 (54.5, 87.6)	0.0 (−9.3, +10.2)	0.38	300
Hypertension	35.2 (19.3, 48.3)	40.0 (22.7, 52.8)	+1.2 (−4.0, +10.9)	<0.001^b	267
Diabetes	42.6 (22.6, 60.6)	46.2 (27.4, 60.0)	+0.1 (−4.3, +9.5)	0.02^b	281
Dyslipidemia	33.3 (19.7, 46.3)	35.1 (22.0, 47.0)	0.0 (−3.8, +6.6)	0.12	268